AvPAK Products: Prescription Medications Section, Page 5

Page 5 of 28 « First Page « … 3 4 5 6 7 … 10 15 20 25 … » Last Page »

Buprenorphine HCl and Naloxone HCl (Buprenorphine and Naloxone)

Buprenorphine and Naloxone Sublingual Tablets are indicated for the maintenance treatment of opioid dependence. Buprenorphine and Naloxone Sublingual Tablets should be used as part of a…

AvPAK5 March 2020

Bupropion Hydrochloride

Bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM).The efficacy of bupropion…

AvPAK20 January 2020

Buspirone Hydrochloride

Buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of…

AvPAK5 November 2020

Calcium Acetate

Calcium acetate USP is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). Calcium acetate capsules USP is a phosphate binder…

AvPAK21 January 2020

Capecitabine

Capecitabine tablets are a nucleoside metabolic inhibitor with antineoplastic activity indicated for: Adjuvant Colon Cancer. (1.1) Patients with Dukes’ C colon cancer. Metastatic…

AvPAK20 January 2020

Page 5 of 28 « First Page « … 3 4 5 6 7 … 10 15 20 25 … » Last Page »

FDA Medwatch

Meitheal Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Cisatracurium Besylate Injection, USP 10mg per 5mL Due to Mislabeling
Tue, 26 Jan 2021. Meitheal Pharmaceuticals, Inc. (“Meitheal”), announced today that it is voluntarily recalling one (1) lot of Cisatracurium Besylate Injection, USP 10mg per 5mL to the user level. The decision to recall the product was made after a product…
Nostrum Laboratories, Inc. Expands Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Sun, 24 Jan 2021. Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg (generic…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.